Overview

Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

Status:
Completed
Trial end date:
2020-12-10
Target enrollment:
Participant gender:
Summary
The objective of this study was to determine the safety, tolerability and pharmacokinetics after single ascending dose of LNA043 in Japanese participants with osteoarthritis of the knee.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis Pharmaceuticals